ロード中...
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients
Targeting the PD-1/PD-L1 immune checkpoint signaling is a novel promising treatment strategy in several tumor entities, and it is suggested that PD-L1/PD-1 expression is predictive for a PD-1/PD-L1 checkpoint inhibitor treatment response. We investigated the expression of PD-L1 and PD-1 by immunohis...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5029700/ https://ncbi.nlm.nih.gov/pubmed/27009855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8169 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|